Kennedy Capital Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.55M Buy
364,777
+259,149
+245% +$6.11M 0.13% 252
2026
Q1
$2.4M Sell
105,628
-25,644
-20% -$606K 0.05% 401
2025
Q4
$3.5M Sell
131,272
-41,847
-24% -$1.24M 0.07% 353
2025
Q3
$5.25M Buy
173,119
+3,426
+2% +$104K 0.12% 286
2025
Q2
$5.32M Buy
169,693
+17,955
+12% +$594K 0.13% 282
2025
Q1
$5.8M Sell
151,738
-6,819
-4% -$289K 0.14% 257
2024
Q4
$6.96M Buy
158,557
+8,743
+6% +$384K 0.15% 234
2024
Q3
$6.45M Buy
149,814
+27,582
+23% +$1.23M 0.14% 252
2024
Q2
$5.52M Buy
122,232
+15,240
+14% +$791K 0.12% 293
2024
Q1
$6.68M Buy
106,992
+62,395
+140% +$3.73M 0.14% 253
2023
Q4
$2.5M Buy
+44,597
New +$2.22M 0.05% 443

Other funds holding ENOV

Kennedy Capital Management's ENOV Position: Q2 2026 in Review

Kennedy Capital Management increased its Enovis (ENOV) stake by 245% in Q2 2026, buying an estimated $6.11M and bringing the position to 364,777 shares worth $7.55M. The position accounts for 0.13% of the portfolio, ranked #252.

Kennedy Capital Management first reported a position in ENOV in Q4 2023 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Kennedy Capital Management held 364,777 shares of Enovis worth $7.55M as of Q2 2026.
  • Kennedy Capital Management bought 259,149 Enovis shares in Q2 2026, an estimated $6.11M.
  • Enovis made up 0.13% of Kennedy Capital Management's portfolio in Q2 2026, its #252 holding.
  • Kennedy Capital Management first reported a position in Enovis in Q4 2023 and has held it in 11 quarters since.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.